In a Chinese examine of 79 unselected sufferers treated with erlotinib no significant correlation amongst EGFR mRNA expression, EGFR mutations, KRAS mutations and medical endpoints was located
One particular individual with EGFR wild-variety and response to BE remedy experienced a KRAS...